Raj Manchanda
Chief Tech/Sci/R&D Officer at NEUMORA THERAPEUTICS, INC.
Profile
Raj Manchanda is currently the Chief Technical Operations Officer at Neumora Therapeutics, Inc. Prior to this, he was the Chief Development Officer at Anokion US, Inc. from 2019 to 2023 and at Frequency Therapeutics, Inc. from 2016 to 2018.
Dr. Manchanda holds a doctorate degree from Yale University.
Raj Manchanda active positions
| Companies | Position | Start |
|---|---|---|
| NEUMORA THERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 2023-06-30 |
Former positions of Raj Manchanda
| Companies | Position | End |
|---|---|---|
| Anokion US, Inc. | Corporate Officer/Principal | 2023-06-30 |
| KORRO BIO, INC. | Corporate Officer/Principal | 2018-09-30 |
Training of Raj Manchanda
| Yale University | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| NEUMORA THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
| Anokion US, Inc. | |
Frequency Therapeutics, Inc.
 Frequency Therapeutics, Inc. BiotechnologyHealth Technology Frequency Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in the business of developing therapeutics to activate a person's innate regenerative potential to restore function. The firm is also involved in creating and commercializing therapeutics to potentially transform the lives of individuals by repairing or reversing damage done to cells, tissue, and organs. The company was founded by Robert S. Langer, David L. Lucchino, Christopher R. Loosey, and Will J. McLean on November 13, 2014 and is headquartered in Lexington, MA. | Health Technology |
- Stock Market
- Insiders
- Raj Manchanda
